8.79
-0.105(-1.18%)
Currency In USD
| Previous Close | 8.89 |
| Open | 9.03 |
| Day High | 9.03 |
| Day Low | 8.73 |
| 52-Week High | 12.65 |
| 52-Week Low | 8.55 |
| Volume | 711,510 |
| Average Volume | 2.38M |
| Market Cap | 2.7B |
| PE | -48.81 |
| EPS | -0.18 |
| Moving Average 50 Days | 9.39 |
| Moving Average 200 Days | 10.27 |
| Change | -0.11 |
If you invested $1000 in Amicus Therapeutics, Inc. (FOLD) 10 years ago, it would be worth $949.73 as of March 13, 2025 at a share price of $8.785. Whereas If you bought $1000 worth of Amicus Therapeutics, Inc. (FOLD) shares 5 years ago, it would be worth $1,062.27 as of March 13, 2025 at a share price of $8.785.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025
GlobeNewswire Inc.
Feb 27, 2025 12:00 PM GMT
PRINCETON, N.J., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in March. TD Cowen 45th Annual Health Care Confer
Amicus Therapeutics to Announce Full-Year 2024 Financial Results on February 19, 2025
GlobeNewswire Inc.
Feb 10, 2025 12:00 PM GMT
PRINCETON, N.J., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Wednesday, February 19, 2025, at 8:30 a.m. ET to discuss financial results
Amicus Therapeutics Announces Presentations and Posters at the 21st Annual WORLDSymposium™ 2025
GlobeNewswire Inc.
Feb 03, 2025 12:00 PM GMT
PRINCETON, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced that two oral presentations and 20 posters across its development programs will be included at the 21st Annual WORLDSymposium™ 2025, being held F